Athos — Full Portfolio
5 tracked investments · listed companies and verified rows first
MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.
BiotechHealthtechMedical DevicesGhent, BE
NexWafe develops technology for photovoltaic wafer production with a focus on improving efficiency, cost-effectiveness, and reducing the carbon footprint of solar cell manufacturing.
Advanced ManufacturingCleantechEnergyNew MaterialsMunich, DE
Dr. Davor Sutija(Co-CEO and CTO)André Seemaier(Co-CEO and CFO)
Co-investorsEIT InnoEnergyAramco Ventures
AMSilk produces biotech-derived silk protein yarns for textile applications including fashion, accessories, and automotive interiors, using fermentation-based bioprocessing instead of traditional sericulture.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsMunich, DE
Co-investorsNovo HoldingsMIG Capital AG
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesCivilization Ventures Management, LlcGlobal Health Investment CorporationIn-Q-TelSherpalo VenturesViking Global Investors
KONUX provides an AI and IoT platform (CoBrix) and monitoring products like KONUX Switch for railway infrastructure, combining sensor data with field observations and inspection reports to predict asset failures and support maintenance planning.
AI & Machine LearningIoTMobility & Transportation
Johanna Leisch LL.M., Executive MBAin
Co-investorsBootstrap EuropeCapmontFOUNDER.orgNew Enterprise Associates (NEA)SalviaTechFounders+5 more
Agro-commodities trading and post-trading platform
Co-investorsAthos CapitalFJ LabsLux CapitalMarket One Capital7percent VenturesNucleus Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














